A case of vitiligo regression in a patient with psoriasis and psoriatic arthritis receiving adalimumab therapy

The article discusses the common pathogenetic pathways of autoimmune skin diseases – psoriasis and vitiligo. Currently proposed treatments for vitiligo do not significantly reduce or completely restore skin pigmentation. The use of adalimumab for 6 years in a patient suffering from psoriasis, psoria...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: N. S. Rudneva, E. V. Natarova, V. N. Sorotskaya, T. G. Sadunashvili
Médium: Artigo
Jazyk:Russo
Vydáno: IMA-PRESS LLC 2021-12-01
Edice:Современная ревматология
Témata:
psoriasis
psoriatic arthritis
generalized vitiligo
adalimumab
tumor necrosis factor α inhibitor
autoimmune diseases.
On-line přístup:https://mrj.ima-press.net/mrj/article/view/1237
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky